Literature DB >> 16145162

Comparison of three different PCR methods for quantifying human papillomavirus type 16 DNA in cervical scrape specimens.

A T Hesselink1, A J C van den Brule, Z M A Groothuismink, M Molano, J Berkhof, C J L M Meijer, P J F Snijders.   

Abstract

We compared real-time LightCycler and TaqMan assays and the GP5+/6+ PCR/enzyme immunoassay (EIA) to assess the human papillomavirus type 16 (HPV16) load in cervical scrape specimens. Both real-time PCR assays determined the HPV16 load in scrape specimens similarly. The level of agreement between these assays and the GP5+/6+ PCR/EIA was low (P = 0.004), suggesting that the latter method is not suited for quantifying HPV16 DNA.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16145162      PMCID： PMC1234115          DOI： 10.1128/JCM.43.9.4868-4871.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996.

Authors:  S Bulk; F J Van Kemenade; L Rozendaal; C J L M Meijer
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

3.  Comparison of quantitative competitive PCR with LightCycler-based PCR for measuring Epstein-Barr virus DNA load in clinical specimens.

Authors:  Servi J C Stevens; Sandra A W M Verkuijlen; Adriaan J C van den Brule; Jaap M Middeldorp
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes.

Authors:  Adriaan J C van den Brule; René Pol; Nathalie Fransen-Daalmeijer; Leo M Schouls; Chris J L M Meijer; Peter J F Snijders
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 5.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

6.  Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study.

Authors:  A M Josefsson; P K Magnusson; N Ylitalo; P Sørensen; P Qwarforth-Tubbin; P K Andersen; M Melbye; H O Adami; U B Gyllensten
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

7.  Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance.

Authors:  Mark van Duin; Peter J F Snijders; Henri F J Schrijnemakers; Feja J Voorhorst; Lawrence Rozendaal; Marielle A E Nobbenhuis; Adriaan J C van den Brule; René H M Verheijen; Theo J Helmerhorst; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2002-04-01       Impact factor: 7.396

8.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

9.  High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women.

Authors:  Jean-Luc Prétet; Véronique Dalstein; Sylvain Monnier-Benoit; Sébastien Delpeut; Christiane Mougin
Journal:  J Clin Virol       Date:  2004-10       Impact factor: 3.168

Review 10.  The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity.

Authors:  Peter J F Snijders; Adriaan J C van den Brule; Chris J L M Meijer
Journal:  J Pathol       Date:  2003-09       Impact factor: 7.996
View more
  14 in total

1.  Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program.

Authors:  A T Hesselink; N W J Bulkmans; J Berkhof; A T Lorincz; C J L M Meijer; P J F Snijders
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

2.  Acquisition and persistence of human papillomavirus 16 (HPV-16) and HPV-18 among men with high-HPV viral load infections in a circumcision trial in Kisumu, Kenya.

Authors:  Virginia Senkomago; Danielle M Backes; Michael G Hudgens; Charles Poole; Kawango Agot; Stephen Moses; Peter J F Snijders; Chris J L M Meijer; Albertus T Hesselink; Nicolas F Schlecht; Robert C Bailey; Jennifer S Smith
Journal:  J Infect Dis       Date:  2014-09-26       Impact factor: 5.226

3.  Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma.

Authors:  Sharon D Stoker; Zlata Novalić; Maarten A Wildeman; Alwin D R Huitema; Sandra A W M Verkuijlen; Hedy Juwana; Astrid E Greijer; I Bing Tan; Jaap M Middeldorp; Jan Paul de Boer
Journal:  J Cancer Res Clin Oncol       Date:  2015-04-29       Impact factor: 4.553

4.  Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort.

Authors:  Frank J M van Kuppeveld; Arjan S de Jong; Kjerstin H Lanke; Gerald W Verhaegh; Willem J G Melchers; Caroline M A Swanink; Gijs Bleijenberg; Mihai G Netea; Jochem M D Galama; Jos W M van der Meer
Journal:  BMJ       Date:  2010-02-25

5.  Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia.

Authors:  A T Hesselink; M A P C van Ham; D A M Heideman; Z M A Groothuismink; L Rozendaal; J Berkhof; F J van Kemenade; L A F G Massuger; W J G Melchers; C J L M Meijer; P J F Snijders
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

6.  Higher HPV16 and HPV18 Penile Viral Loads Are Associated With Decreased Human Papillomavirus Clearance in Uncircumcised Kenyan Men.

Authors:  Virginia Senkomago; Danielle M Backes; Michael G Hudgens; Charles Poole; Steven R Meshnick; Kawango Agot; Stephen Moses; Peter Jf Snijders; Chris Jlm Meijer; Albertus T Hesselink; Nicolas F Schlecht; Robert C Bailey; Jennifer S Smith
Journal:  Sex Transm Dis       Date:  2016-09       Impact factor: 2.830

7.  PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro.

Authors:  Florianne E Henken; N Sanjib Banerjee; Peter J F Snijders; Chris J L M Meijer; Johanna De-Castro Arce; Frank Rösl; Thomas R Broker; Louise T Chow; Renske D M Steenbergen
Journal:  Mol Cancer       Date:  2011-06-10       Impact factor: 27.401

8.  Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women.

Authors:  N Muñoz; G Hernandez-Suarez; F Méndez; M Molano; H Posso; V Moreno; R Murillo; M Ronderos; C Meijer; A Muñoz
Journal:  Br J Cancer       Date:  2009-03-17       Impact factor: 7.640

9.  Zip Nucleic Acids: new high affinity oligonucleotides as potent primers for PCR and reverse transcription.

Authors:  Valérie Moreau; Emilie Voirin; Clément Paris; Mitsuharu Kotera; Marc Nothisen; Jean-Serge Rémy; Jean-Paul Behr; Patrick Erbacher; Nathalie Lenne-Samuel
Journal:  Nucleic Acids Res       Date:  2009-08-20       Impact factor: 16.971

10.  Can quantifying free-circulating DNA in plasma be used to identify subjects with high-grade pre-invasive endobronchial lesions?

Authors:  Robert A A VAN Boerdonk; Hes A P Brokx; Pyng Lee; Clarissa Kooi; Pieter E Postmus; Peter J F Snijders; Katrien Grünberg; Erik Thunnissen; Thomas G Sutedja; Johannes M A Daniels; Daniëlle A M Heideman
Journal:  Oncol Lett       Date:  2013-03-19       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.